Celecoxib

cadherin 1 ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35176901 Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma. 2022 Jan-Dec 1
2 32269737 Selective EP2 and Cox-2 inhibition suppresses cell migration by reversing epithelial-to-mesenchymal transition and Cox-2 overexpression and E-cadherin downregulation are implicated in neck metastasis of hypopharyngeal cancer. 2020 3
3 31114336 Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2. 2019 1
4 29932878 COX-2 inhibition by celecoxib in epithelial ovarian cancer attenuates E-cadherin suppression through reduced Snail nuclear translocation. 2018 Aug 25 2
5 28053596 Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. 2017 1
6 27528025 Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1. 2016 Aug 30 1
7 25424898 Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression. 2015 Jun 1
8 24887090 Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. 2014 May 10 1
9 23670240 COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer. 2013 Jul 1
10 24115825 Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells. 2013 Oct 7 2
11 21882253 Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells. 2012 Oct 1
12 21215211 [Influence of celecoxib on invasiveness of human high-metastatic nasopharyngeal carcinoma cell line CNE-2Z]. 2010 Nov 3
13 19622294 [Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues]. 2009 Apr 7
14 19940363 Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines. 2009 1
15 18303430 Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin. 2008 Feb 1
16 17224647 Effect of celecoxib on E-cadherin, VEGF, Microvessel density and apoptosis in gastric cancer. 2007 Feb 3